ACE2 and COVID-19: As observed in the COVID-19, the innate immune system functions as the first line of host defence, which is activated as the SARS-CoV-2 engages the angiotensin-converting enzyme 2 (ACE2) receptor to enter the cell and employs the cellular serine protease TMPRSS2 for its spike (S) protein priming (36).